FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1033994473> ?p ?o ?g. }

• W1033994473 startingPage "12" @default.
• W1033994473 abstract "A basic tenet of biological psychiatry is that place bo-controlled, randomized drug trials under double blind have shown that antidepressants exert pharmacological efficacy-in other words, that they induce specific and measurable drug effects on research subjects. But there is ongoing dissention about whether pharmacological efficacy has been established reliably by these trials. The antidepressant debate indicates a split in the expert clinical community about the size of the drug/placebo difference and whether the mechanisms that produce it stem from the subjects' expectation of benefit or from the intervention's pharmacological prop erties. A basic tenet of research ethics is that if standard effective treatments exist, then clinical equipoise requires their use as active controls against which novel, nonvali dated treatments are tested. Substituting a placebo for an effective treatment in the control arm of a trial does not maintain this duty, as it exposes research subjects to an intervention that is known to be inferior. Defenders of clinical equipoise argue that conducting a trial is not an invitation to practice substandard medicine.' They have also argued that legal liability concerns might be raised about placebo-controlled trials of antidepressants.2 These ethical and legal concerns can be assessed with reference to cases in which clinical equipoise permits placebo-controlled trials. Given the recurring questions about whether the drug/placebo difference results from specific biological effects of antidepressants or from fac tors introduced by placebo response that have not been adequately excluded, I think a plausible argument can be made that clinical equipoise would permit the use of active placebo controls in the clinical trials that test them. This argument can be abbreviated to three premises and a conclusion. The first premise is that placebo con trols for drug trials are ethically defensible and scientifi cally justified when we have evidence leading to a rea sonable concern that a standard treatment might only work because of expectancy enhanced by side effects i.e., by enhanced placebo effects. The second premise is that this evidence must be endorsed by at least a respectable minority of the expert clinical community. Premise three asserts that a respectable minority of the expert clinical community endorses evidence leading to a reasonable concern that standard antidepressants might only work by enhanced placebo effects. If these premises are sound, then one can conclude that placebo controls for antidepressant trials are ethically defensible and sci entifically justified." @default.
• W1033994473 created "2016-06-24" @default.
• W1033994473 creator A5044153176 @default.
• W1033994473 date "2008-11-01" @default.
• W1033994473 modified "2023-09-23" @default.
• W1033994473 title "The antidepressant debate and ethically defensible placebo-controlled trials." @default.
• W1033994473 cites W1587726701 @default.
• W1033994473 cites W1769688440 @default.
• W1033994473 cites W1959108287 @default.
• W1033994473 cites W1998045956 @default.
• W1033994473 cites W2033765149 @default.
• W1033994473 cites W2042806143 @default.
• W1033994473 cites W2052056241 @default.
• W1033994473 cites W2101100546 @default.
• W1033994473 cites W2115475431 @default.
• W1033994473 cites W2125933784 @default.
• W1033994473 cites W2143895290 @default.
• W1033994473 cites W2151623812 @default.
• W1033994473 cites W2409223290 @default.
• W1033994473 cites W2470338566 @default.
• W1033994473 cites W2951053490 @default.
• W1033994473 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19119759" @default.
• W1033994473 hasPublicationYear "2008" @default.
• W1033994473 type Work @default.
• W1033994473 sameAs 1033994473 @default.
• W1033994473 citedByCount "0" @default.
• W1033994473 crossrefType "journal-article" @default.
• W1033994473 hasAuthorship W1033994473A5044153176 @default.
• W1033994473 hasConcept C118552586 @default.
• W1033994473 hasConcept C126322002 @default.
• W1033994473 hasConcept C142724271 @default.
• W1033994473 hasConcept C15744967 @default.
• W1033994473 hasConcept C168563851 @default.
• W1033994473 hasConcept C177713679 @default.
• W1033994473 hasConcept C204787440 @default.
• W1033994473 hasConcept C27081682 @default.
• W1033994473 hasConcept C2775919319 @default.
• W1033994473 hasConcept C2779177272 @default.
• W1033994473 hasConcept C2780665704 @default.
• W1033994473 hasConcept C535046627 @default.
• W1033994473 hasConcept C542102704 @default.
• W1033994473 hasConcept C558461103 @default.
• W1033994473 hasConcept C71924100 @default.
• W1033994473 hasConceptScore W1033994473C118552586 @default.
• W1033994473 hasConceptScore W1033994473C126322002 @default.
• W1033994473 hasConceptScore W1033994473C142724271 @default.
• W1033994473 hasConceptScore W1033994473C15744967 @default.
• W1033994473 hasConceptScore W1033994473C168563851 @default.
• W1033994473 hasConceptScore W1033994473C177713679 @default.
• W1033994473 hasConceptScore W1033994473C204787440 @default.
• W1033994473 hasConceptScore W1033994473C27081682 @default.
• W1033994473 hasConceptScore W1033994473C2775919319 @default.
• W1033994473 hasConceptScore W1033994473C2779177272 @default.
• W1033994473 hasConceptScore W1033994473C2780665704 @default.
• W1033994473 hasConceptScore W1033994473C535046627 @default.
• W1033994473 hasConceptScore W1033994473C542102704 @default.
• W1033994473 hasConceptScore W1033994473C558461103 @default.
• W1033994473 hasConceptScore W1033994473C71924100 @default.
• W1033994473 hasIssue "6" @default.
• W1033994473 hasLocation W10339944731 @default.
• W1033994473 hasLocation W10339944732 @default.
• W1033994473 hasOpenAccess W1033994473 @default.
• W1033994473 hasPrimaryLocation W10339944731 @default.
• W1033994473 hasRelatedWork W119062257 @default.
• W1033994473 hasRelatedWork W1549376468 @default.
• W1033994473 hasRelatedWork W1558033616 @default.
• W1033994473 hasRelatedWork W181652753 @default.
• W1033994473 hasRelatedWork W1969829640 @default.
• W1033994473 hasRelatedWork W1998045956 @default.
• W1033994473 hasRelatedWork W2017182583 @default.
• W1033994473 hasRelatedWork W203298905 @default.
• W1033994473 hasRelatedWork W2088847896 @default.
• W1033994473 hasRelatedWork W2135074062 @default.
• W1033994473 hasRelatedWork W2170610353 @default.
• W1033994473 hasRelatedWork W2400655181 @default.
• W1033994473 hasRelatedWork W2405345668 @default.
• W1033994473 hasRelatedWork W2509749933 @default.
• W1033994473 hasRelatedWork W2533279709 @default.
• W1033994473 hasRelatedWork W2742213613 @default.
• W1033994473 hasRelatedWork W2885983544 @default.
• W1033994473 hasRelatedWork W2902317390 @default.
• W1033994473 hasRelatedWork W66571169 @default.
• W1033994473 hasRelatedWork W8736461 @default.
• W1033994473 hasVolume "30" @default.
• W1033994473 isParatext "false" @default.
• W1033994473 isRetracted "false" @default.
• W1033994473 magId "1033994473" @default.
• W1033994473 workType "article" @default.